Your browser doesn't support javascript.
loading
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Zhou, Tienan; Gong, Yinghui; Li, Jingyuan; Wang, Yasong; Wang, Xiaozeng.
Affiliation
  • Zhou T; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
  • Gong Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
  • Li J; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
  • Wang Y; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China.
  • Wang X; Department of Cardiology, General Hospital of Northern Theater Command, No. 83 Wenhua Rd, Shenyang, 110016, Liaoning, China. wxiaozeng@163.com.
Trials ; 24(1): 209, 2023 Mar 21.
Article in En | MEDLINE | ID: mdl-36945020

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Aspirin / Percutaneous Coronary Intervention / Rivaroxaban / Clopidogrel / Gastrointestinal Diseases / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Aspirin / Percutaneous Coronary Intervention / Rivaroxaban / Clopidogrel / Gastrointestinal Diseases / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: